BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7931666)

  • 1. Cancer or inflammation? A Holy Grail for nuclear medicine.
    Larson SM
    J Nucl Med; 1994 Oct; 35(10):1653-5. PubMed ID: 7931666
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a role for FDG PET imaging in the management of patients with sarcoidosis?
    Alavi A; Buchpiguel CA; Loessner A
    J Nucl Med; 1994 Oct; 35(10):1650-2. PubMed ID: 7931665
    [No Abstract]   [Full Text] [Related]  

  • 3. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
    Lewis PJ; Salama A
    J Nucl Med; 1994 Oct; 35(10):1647-9. PubMed ID: 7931664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High fluorine-18 labeled deoxyglucose uptake in sarcoidosis.
    Yasuda S; Shohtsu A; Ide M; Takagi S; Ogawa J; Mitomi T; Suzuki Y
    Clin Nucl Med; 1996 Dec; 21(12):983-4. PubMed ID: 8957624
    [No Abstract]   [Full Text] [Related]  

  • 5. PET with fluorine-18 deoxyglucose for pancreatic disease.
    Klever P; Bares R; Fass J; Büll U; Schumpelick V
    Lancet; 1992 Nov; 340(8828):1158-9. PubMed ID: 1359226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Usefulness of fluorine-18 fluoro-2-deoxyglucose positron emission tomography for diagnosis and therapy assessment of cardiac sarcoidosis].
    Ishida Y; Nakatani S; Tachibana T
    J Cardiol; 2000 Apr; 35(4):301-4. PubMed ID: 10791274
    [No Abstract]   [Full Text] [Related]  

  • 7. [67-Gallium citrate gammagraphy in the study of lymphomas].
    Ricart Y
    Rev Esp Med Nucl; 2002 Apr; 21(2):85-7. PubMed ID: 11879615
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of oncology protocol using fluorine-18-FDG: one center's experience.
    Cronin V; Galantowicz P; Nabi HA
    J Nucl Med Technol; 1997 Mar; 25(1):66-9. PubMed ID: 9239608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of cancers by FDG-PET].
    Ichiya Y
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):7-10. PubMed ID: 9091463
    [No Abstract]   [Full Text] [Related]  

  • 10. PET cancer evaluations with FDG.
    Hawkins RA; Hoh C; Dahlbom M; Choi Y; Glaspy J; Tse N; Slamon D; Chen B; Messa C; Maddahi J
    J Nucl Med; 1991 Aug; 32(8):1555-8. PubMed ID: 1869978
    [No Abstract]   [Full Text] [Related]  

  • 11. Positron emission tomography, bronchogenic carcinoma, and the adrenals.
    Lamki LM
    AJR Am J Roentgenol; 1997 May; 168(5):1361-2. PubMed ID: 9129445
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a future for PET in oncology?
    Price P
    Eur J Nucl Med; 1997 Jun; 24(6):587-9. PubMed ID: 9235296
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental study for cancer diagnosis with 18FDG: differential diagnosis of inflammation from malignant tumor].
    Fukuda H; Yoshioka S; Watanuki S; Kiyosawa M; Sato T; Matsuzawa T; Takahashi T; Ido T
    Kaku Igaku; 1983 Sep; 20(8):1189-92. PubMed ID: 6672371
    [No Abstract]   [Full Text] [Related]  

  • 14. SUV: standard uptake or silly useless value?
    Keyes JW
    J Nucl Med; 1995 Oct; 36(10):1836-9. PubMed ID: 7562051
    [No Abstract]   [Full Text] [Related]  

  • 15. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67.
    Kubota K; Ishiwata K; Kubota R; Yamada S; Tada M; Sato T; Ido T
    J Nucl Med; 1991 Nov; 32(11):2118-23. PubMed ID: 1834814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomographic oncology.
    Lawson MA
    West J Med; 1994 Oct; 161(4):411-2. PubMed ID: 7817554
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluorodeoxyglucose (FDG) and tumour metabolism.
    Van Wyngaarden KE; Pauwels EK
    Nucl Med Commun; 1995 Dec; 16(12):987-9. PubMed ID: 8719978
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue characterization in nuclear oncology: its time has come.
    Lamki LM
    J Nucl Med; 1995 Feb; 36(2):207-10. PubMed ID: 7830115
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method?
    Mankoff DA; Muzi M; Krohn KA
    Mol Imaging Biol; 2003; 5(5):281-5. PubMed ID: 14630508
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of positron-emission tomography in oncology].
    Strauss LG; Kabelitz D; Kremer B; Lode H; Meinertz T; Sauerbruch T; Sterry W
    Dtsch Med Wochenschr; 1996 Feb; 121(7):207-9. PubMed ID: 8681765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.